To make an award under HHS-NIH-niaid-BAA2018
Active Definitive Contract Awarded Last action
- Contract number
- 75N93019C00056
- Awardee
-
Crestone, Inc. UEI EDSLAP2J1BL8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $33,109,378
Award facts
- Opportunity
-
- HHSNIHNIAIDBAA2018 Solicitation number
- Research Area 003 - Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Award Notice · Posted Jun 1, 2018
- Contract value 100% obligated
- $33,109,378.19 Current and potential, with all options
- Completion date 97% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Boulder, CO 80301, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$184,875 | |
| Other Administrative Action | $0 | |
| Change Order | $1,350,620 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $3,330,593 | |
| Change Order | $573,467 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $4,595,632 | |
| Funding Only Action | $3,511,044 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $4,519,619 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $850,507 | |
| Exercise an Option | $9,777,293 | |
| Change Order | $1,345,704 | |
| Other Administrative Action | $0 | |
| Original award | $3,439,774 |
Show all 19
About this award
The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Crestone, Inc. on September 9, 2019, with a ceiling value of $33.1 million under a cost-plus-fixed-fee pricing structure. The award is made without set-aside.
The underlying action is to administrate de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of those funds. Place of performance is Boulder, Colorado.
Service Contract Inventory reporting shows the contract has remained active through fiscal year 2025 with declining direct labor intensity. FY2021 invoiced $4.5 million across 6.5 FTEs and 13,534 contractor hours; FY2025 invoiced $6.4 million across 2.4 FTEs. The derived government-paid hourly rate rose from $334.53 per hour in FY2021 to $405.63 per hour in FY2024, reflecting a blended prime and subcontractor rate. In FY2025, Crestone self-performed all reported work without subcontractors. Ultimate completion date is January 31, 2027.
Quick answers
Who was awarded contract 75N93019C00056?
75N93019C00056 was awarded to Crestone, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 9, 2019.
How much is contract 75N93019C00056 worth?
The government has obligated $33,109,378 on 75N93019C00056.
Was contract 75N93019C00056 competed?
The extent of competition for 75N93019C00056 was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award